Search Results

• • 13 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Drug-company sponsorship and the Declaration of Helsinki

  Authors:James E Tcheng, J Conor O'Shea, and David L BrownFrom:The Lancet (Vol. 357, Issue 9266) Peer-Reviewed

  May 5, 2001 Brief article, Lette...

   Citation Only

• Statistical issues relating to international differences in clinical trials

  Authors:J. Conor O'Shea and David L. DeMetsFrom:American Heart Journal (Vol. 142, Issue 1) Peer-Reviewed

  July 2001 Article

   Citation Only

• Potential impact of socioeconomic differences on clinical outcomes in international clinical trials

  Authors:Marcelo C. Shibata, Marcus D. Flather, Diego Perez de Arenaza, Duolao Wang, and J. Conor O'SheaFrom:American Heart Journal (Vol. 141, Issue 6) Peer-Reviewed

  June 2001 Article

   Citation Only

• Highlights from the American Heart Association Annual Scientific Sessions 2001: November 11 to 14, 2001

  Authors:David E. Kandzari, Joseph Kay, J. Conor O'Shea, Benjamin H. Trichon, Mark Donahue, Lawrence Liao, et al.From:American Heart Journal (Vol. 143, Issue 2) Peer-Reviewed

  Feb. 2002 Article

   Citation Only

• Design and methodology of the ESPRIT trial: evaluating a novel dosing regimen of eptifibatide in percutaneous coronary intervention

  Authors:J. Conor O'Shea, Mina Madan, Warren J. Cantor, Cynthia M. Pacchiana, Sally Greenberg, Diane M. Joseph, et al.From:American Heart Journal (Vol. 140, Issue 6) Peer-Reviewed

  Dec. 2000 Article

   Citation Only

• Platelet Glycoprotein IIb/IIIa Integrin Blockade With Eptifibatide in Coronary Stent Intervention: A Randomized Controlled Trial

  Authors:J. Conor O'Shea, Gail E. Hafley, Sally Greenberg, Vic Hasselblad, Todd J. Lorenz, Michael M. Kitt, et al.From:JAMA, The Journal of the American Medical Association (Vol. 285, Issue 19) Peer-Reviewed

  May 16, 200148 words Product/service eval...

   Abstract Only

• International differences in treatment effects in cardiovascular clinical trials

  Authors:J. Conor O'Shea and Robert M. CaliffFrom:American Heart Journal (Vol. 141, Issue 5) Peer-Reviewed

  May 2001 Article

   Citation Only

• Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention. (Brief Report)

  Authors:J. Conor O'Shea, Christopher E. Buller, Warren J. Cantor, A. Bleakley Chandler, Eric A. Cohen, David J. Cohen, et al.From:JAMA, The Journal of the American Medical Association (Vol. 287, Issue 5) Peer-Reviewed

  Feb. 6, 2002331 words Article

   Abstract Only

• International differences in cardiovascular clinical trials

  Authors:J. Conor O'Shea and Robert M. CaliffFrom:American Heart Journal (Vol. 141, Issue 5) Peer-Reviewed

  May 2001 Article

   Citation Only

• Introduction

  Authors:J. Conor O'Shea and Robert M. CaliffFrom:American Heart Journal (Vol. 141, Issue 5) Peer-Reviewed

  May 2001 Article

   Citation Only

• 24-Hour ambulatory blood pressure monitoring

  Authors:J. Conor O'Shea and Robert M. CaliffFrom:American Heart Journal (Vol. 151, Issue 5) Peer-Reviewed

  May 200697 words Article

   Abstract Only

• 24-hour ambulatory blood pressure monitoring

  Authors:J. Conor O'Shea and Robert M. CaliffFrom:American Heart Journal (Vol. 151, Issue 5) Peer-Reviewed

  May 2006 Article

   Citation Only

• A tale of two countries: insights from the differences in Canadian/American patterns of care for patients with acute coronary syndromes

  Authors:J. Conor O'Shea, Yuling Fu, Wei-Ching Chang, and Paul W. ArmstrongFrom:American Heart Journal (Vol. 142, Issue 1) Peer-Reviewed

  July 2001 Article

   Citation Only